0001127602-24-013718.txt : 20240501 0001127602-24-013718.hdr.sgml : 20240501 20240501114742 ACCESSION NUMBER: 0001127602-24-013718 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240430 FILED AS OF DATE: 20240501 DATE AS OF CHANGE: 20240501 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Tarr Mark J CENTRAL INDEX KEY: 0001304057 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-10315 FILM NUMBER: 24901425 MAIL ADDRESS: STREET 1: C/O ENCOMPASS HEALTH CORPORATION STREET 2: 9001 LIBERTY PARKWAY CITY: BIRMINGHAM STATE: AL ZIP: 35242 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Encompass Health Corp CENTRAL INDEX KEY: 0000785161 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HOSPITALS [8060] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 630860407 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9001 LIBERTY PARKWAY CITY: BIRMINGHAM STATE: AL ZIP: 35242 BUSINESS PHONE: 205-967-7116 MAIL ADDRESS: STREET 1: 9001 LIBERTY PARKWAY CITY: BIRMINGHAM STATE: AL ZIP: 35242 FORMER COMPANY: FORMER CONFORMED NAME: HEALTHSOUTH CORP DATE OF NAME CHANGE: 19950113 FORMER COMPANY: FORMER CONFORMED NAME: HEALTHSOUTH REHABILITATION CORP DATE OF NAME CHANGE: 19920703 4 1 form4.xml PRIMARY DOCUMENT X0508 4 2024-04-30 0000785161 Encompass Health Corp EHC 0001304057 Tarr Mark J 2537 WATKINS ROAD MOUNTAIN BROOK AL 35223 1 1 President & CEO 0 Encompass Health Common Stock 2024-04-30 4 M 0 19460 35.83 A 573558 D Encompass Health Common Stock 2024-04-30 4 M 0 25516 29.06 A 599074 D Encompass Health Common Stock 2024-04-30 4 S 0 44976 83.27 D 554098 D Non-qualified Stock Option (Right to Buy) 35.83 2024-04-30 4 M 0 19460 0 D 2016-03-03 2025-03-03 Encompass Health Common Stock 19460 0 D Non-qualified Stock Option (Right to Buy) 29.06 2024-04-30 4 M 0 25516 0 D 2017-02-26 2026-02-26 Encompass Health Common Stock 25516 0 D This per share price is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $83.25 to $83.53, inclusive. The reporting person undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within this range. The exercise price and number of options reported have been adjusted, pursuant to Article 17 of the 2016 Omnibus Performance Incentive Plan, for the spin-off distribution of the common stock of Enhabit, Inc. /s/ Patrick Darby, attorney-in-fact for Mark J. Tarr 2024-05-01